Addiction

Call for Papers- Drug Addiction Research in China

Drug addiction has been a major public health problem bringing a heavy burden to patients, families and society in China historically and contemporarily. In the recent two decades, animal and clinical research on mechanisms, trajectories, prevention and treatments of drug addiction has flourished in China, and progress and breakthroughs have been made in revealing the genetic basis and neural circuits of drug addiction, as well as discovering novel therapies, especially behavioural and neuromodulating interventions. The

Implementing Adolescent SBIRT

Soberay, A., DeSorrento, L., Pietruszewski, P., Sitz, M., & Levy, S. (2021). Implementing adolescent SBIRT: Findings from the FaCES project. Substance abuse, 42(4), 751-759.

Screening, Brief Intervention, and Referral to Treatment (SBIRT) is an evidence-based approach to early intervention of substance use.

This mixed-methods evaluation assessed the implementation of an adolescent SBIRT change package across 13 primary care clinics in the United States. These clinics participated in an 18-month learning collaborative, during which they received training and technical assistance on SBIRT practices. 

Words Matter Language Guide

Published by
INPUD and ANPUD

The need to change our language in relation to people who use drugs has become an increasing topic of discussion, but there is still a long way to go. People who use drugs are highly diverse and their relationship with drug use takes many different forms. Current prohibitionist approaches to drug use and ‘war on drugs’ rhetoric do little to encourage language that acknowledges this diversity.

Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study

Moore, B. F., Sauder, K. A., Shapiro, A. L., Crume, T., Kinney, G. L., & Dabelea, D. (2022). Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study. The Journal of Clinical Endocrinology & Metabolism, 20, 1-8.
Publication Date
Abstract
Objective

To assess the impact of fetal exposure to cannabis on adiposity and glucose-insulin traits in early life.

Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial

Janzow, G. E., Harding, C., Flores, M., Borodovsky, J., Steinkamp, J., Marsch, L. A., & Schuman-Olivier, Z. (2022). Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial. Drug and Alcohol Dependence Reports, 3, 100045.

Abstract

Background

Increasing buprenorphine/naloxone (B/N) access for opioid use disorder (OUD) is essential yet ensuring adherence and preventing diversion remains challenging. This study examines the feasibility, usability, and acceptability of MySafeRx, a mobile platform integrating motivational coaching, adherence monitoring, and electronic dispensing during office-based B/N treatment.

The Lost Wisdom of Women: Reclaiming Our Recovery

Online,

Friday, May 6, 2022 @ 12:00-1:30pm ET (11CT/10MT/9PT)

Description

The Achilles heel for many women in or seeking recovery is tied to unhealthy and toxic relationships, from family of origin to adult romances. This presentation will use powerful keys from family systems theory to provide practical tools for getting free from limiting beliefs that fuel negative relational cycles during the recovery process.

Neurofeedback for opioid dependent patients in an outpatient setting: a pilot feasibility study

Rempala, H.A., Barterian, J.A. Neurofeedback for opioid dependent patients in an outpatient setting: a pilot feasibility study. Subst Abuse Treat Prev Policy 17, 28 (2022). https://doi.org/10.1186/s13011-022-00458-2
Publication Date

Background

When used in combination with other therapies for drug use disorders, neurofeedback (NF) has been classified as "probably effective," according to recent research in the community of people with opioid use disorder.

Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults

Nishimi K, Neylan TC, Bertenthal D, Seal KH, O’Donovan A. Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults. JAMA Netw Open. 2022;5(4):e227287. doi:10.1001/jamanetworkopen.2022.7287
Publication Date
Abstract

Importance  Psychiatric disorders may be associated with an increased risk for SARS-CoV-2 breakthrough infection after vaccination, but no studies have tested this hypothesis.

Objective  To evaluate whether past diagnoses of psychiatric disorders are associated with an increased incidence of SARS-CoV-2 breakthrough infection among fully vaccinated individuals.

Advances in Addiction and Recovery

Published by
NAADAC

Advances in Addiction & Recovery, the official publication of NAADAC, is a quarterly digital magazine focused on providing useful, innovative and timely information on trends and best practices in the profession that are beneficial for addiction professionals.  

The winter 2022 issue of the magazine is now available to everyone.